Tek Image/science Photo Library | Science Photo Library | Getty Images Japanese drugmaker Eisai expects the Food and Drug Administration to fully approve its Alzheimer’s treatment Leqembi this s...
Tag: Leqembi
Patients would pay up to $26,500 per year for Leqembi
Few seniors with early Alzheimer’s disease will have access to the new treatment Leqembi due to its high cost and very limited coverage by Medicare. The Food and Drug Administration on Friday gr...